Engineers Gate Manager LP Ptc Therapeutics, Inc. Transaction History

Engineers Gate Manager LP

$8.12 Billion
Q3 2025

A detailed history of Engineers Gate Manager LP transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Engineers Gate Manager LP holds 11,223 shares of PTCT stock, worth $845,091. This represents 0.01% of its overall portfolio holdings.

Number of Shares

11,223

Previous 24,354 53.92%

Holding current value

$845,091

Previous $1.19 Million 42.14%

% of portfolio

0.01%

Previous 0.02%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$43.3 - $62.88 $568,572 - $825,677	-13,131 Reduced 53.92%	11,223 $688,000
Q2 2025 Aug 14, 2025	SELL	$36.19 - $52.13 $1.33 Million - $1.91 Million	-36,622 Reduced 60.06%	24,354 $1.19 Million
Q1 2025 May 15, 2025	BUY	$41.81 - $57.17 $1.03 Million - $1.41 Million	24,683 Added 68.01%	60,976 $3.11 Million
Q4 2024 Feb 14, 2025	SELL	$34.99 - $52.07 $410,642 - $611,093	-11,736 Reduced 24.44%	36,293 $1.64 Million
Q3 2024 Nov 14, 2024	SELL	$30.39 - $37.66 $1.41 Million - $1.74 Million	-46,256 Reduced 49.06%	48,029 $1.78 Million

Q2 2024 Aug 14, 2024	BUY	$24.69 - $40.12 $705,615 - $1.15 Million	28,579 Added 43.5%	94,285 $2.88 Million
Q1 2024 May 15, 2024	SELL	$24.15 - $31.95 $91,987 - $121,697	-3,809 Reduced 5.48%	65,706 $1.91 Million
Q4 2023 Feb 14, 2024	BUY	$18.07 - $29.37 $395,949 - $643,555	21,912 Added 46.03%	69,515 $1.92 Million
Q3 2023 Nov 14, 2023	BUY	$22.41 - $41.99 $894,943 - $1.68 Million	39,935 Added 520.8%	47,603 $1.07 Million
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $309,787 - $453,178	7,668 New	7,668 $311,000
Q4 2022 Feb 14, 2023	BUY	$33.53 - $54.79 $15,356 - $25,093	458 Added 4.87%	9,864 $376,000
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $110,400 - $142,056	2,638 Added 38.98%	9,406 $472,000
Q2 2022 Aug 15, 2022	SELL	$25.6 - $45.23 $6,041 - $10,674	-236 Reduced 3.37%	6,768 $271,000
Q1 2022 May 16, 2022	BUY	$33.33 - $44.6 $233,443 - $312,378	7,004 New	7,004 $261,000
Q4 2021 Feb 14, 2022	SELL	$35.36 - $41.86 $958,821 - $1.14 Million	-27,116 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$37.01 - $44.74 $1 Million - $1.21 Million	27,116 New	27,116 $1.01 Million
Q2 2021 Aug 16, 2021	SELL	$37.95 - $49.37 $214,797 - $279,434	-5,660 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $203,018 - $298,974	-4,338 Reduced 43.39%	5,660 $268,000
Q4 2020 Feb 16, 2021	SELL	$47.96 - $67.64 $7,241 - $10,213	-151 Reduced 1.49%	9,998 $610,000
Q3 2020 Nov 16, 2020	BUY	$45.41 - $57.07 $460,866 - $579,203	10,149 New	10,149 $474,000
Q2 2020 Aug 17, 2020	SELL	$42.56 - $54.98 $716,029 - $924,983	-16,824 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$32.37 - $59.36 $306,317 - $561,723	9,463 Added 128.56%	16,824 $751,000
Q4 2019 Feb 14, 2020	SELL	$32.22 - $50.07 $541,650 - $841,726	-16,811 Reduced 69.55%	7,361 $354,000
Q3 2019 Nov 14, 2019	BUY	$33.82 - $48.17 $817,497 - $1.16 Million	24,172 New	24,172 $817,000

Others Institutions Holding PTCT

# of Institutions

325

Shares Held

83.2M

Call Options Held

811K

Put Options Held

207K

View Full List

About PTC THERAPEUTICS, INC.

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $5.39B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

More about PTCT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Engineers Gate Manager LP, based on Form 13F filings with the SEC.

News

Stay updated on Engineers Gate Manager LP with notifications on news.

Account

Engineers Gate Manager LP Ptc Therapeutics, Inc. Transaction History